Joshua Smith

Stock Analyst at Redburn Atlantic

(1.63)
# 3,159
Out of 4,843 analysts
3
Total ratings
50%
Success rate
0.89%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Joshua Smith

Alnylam Pharmaceuticals
Mar 31, 2025
Initiates: Buy
Price Target: $353
Current: $304.56
Upside: +15.90%
BridgeBio Pharma
Mar 31, 2025
Initiates: Buy
Price Target: $50
Current: $34.25
Upside: +45.99%
Ionis Pharmaceuticals
Mar 31, 2025
Initiates: Neutral
Price Target: $39
Current: $33.51
Upside: +16.38%